Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
for Hemophilia A
3 locations incl. New Hyde Park
Sponsor: Pfizer
Sex: Male·Age: 1 - 74
Code: NCT05145127·Phase 3·Recruiting·Listed Dec 2021
The Feinstein Institutes for Medical Research
Clinical research site in Philadelphia, Pennsylvania
Part of Feinstein Institutes for Medical Research
As of July 2026, 1 paid clinical trial is recruiting at The Feinstein Institutes for Medical Research in Philadelphia, Pennsylvania. Active studies at this site cover conditions such as Hemophilia A and Hemophilia B. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at The Feinstein Institutes for Medical Research (1)
More research sites in Philadelphia
- University of Pennsylvania (357 trials)
- Children's Hospital of Philadelphia (306 trials)
- Thomas Jefferson University Hospital (112 trials)
- Thomas Jefferson University (95 trials)
- Fox Chase Cancer Center (94 trials)
- Hospital of the University of Pennsylvania (87 trials)
- The Children's Hospital of Philadelphia (42 trials)
- Temple University (39 trials)
- Temple University Hospital (38 trials)
- University of Pennsylvania/Abramson Cancer Center (30 trials)
Explore more
Paid clinical trials in Philadelphia, PA · Pennsylvania clinical trials